Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: A Study of PF-07260437 in Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of PF-07260437 in advanced or metastatic solid tumors was terminated, with results posted on 2025-05-06.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: A Study of LY2880070 in Participants With Advanced or Metastatic Cancer [Phase 1, Phase 2]
Esperas Pharma completed a Phase 1/2 study of LY2880070 in adults with advanced or metastatic cancer, including colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of relacorilant with nab-paclitaxel in recurrent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer has …
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors [NA]
A completed clinical trial evaluating the Carevive Survivor Care Planning System for improving quality of life in breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: CAR T Cells in Mesothelin Expressing Cancers [Phase 1]
Phase 1 study evaluating mesothelin-targeted CAR T cells in mesothelin-expressing cancers; results have been posted for a University of Penn…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer [NA]
The study examines prehabilitation during the neoadjuvant window in older women with ovarian cancer, and the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer
This update notes the completion of a clinical trial evaluating geriatric assessment plus nursing telephone support for elderly women with o…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 safety and tolerability study of NC762 in patients with advanced or metastatic solid tumors has been terminated, with results po…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Improved Early Diagnosis in Female Pelvic Cancer With OC Detect
A completed clinical trial update reports that OC Detect improves early diagnosis for ovarian and endometrial cancers.
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma [Phase 2]
This Phase 2 trial of autologous tumor-infiltrating lymphocytes (MDA-TIL) in recurrent or refractory ovarian cancer, colorectal cancer, and …
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating AK112 in combination with chemotherapy and/or Olaparib for platinum-sensitive ovarian cancer; recruitment …
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]
Phase 3 study comparing IBI354 to investigator's choice chemotherapy in platinum-resistant ovarian, primary peritoneal, or fallopian tube ca…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel [Phase 1]
Phase 1 study evaluating the safety and tolerability of a PARP inhibitor in combination with carboplatin and/or paclitaxel in patients with …
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1 [Phase 1]
Phase 1 study evaluating the molecular imaging agent [123I]I-DARPIN-Ec1 targeting EpCAM receptors in lung cancer and ovarian cancer has comp…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO
A completed clinical trial update on using new molecular markers to guide personalized therapy for ovarian cancer (the MEMENTO study).
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer [Phase 3]
This document reports a completed Phase 3 trial comparing atezolizumab with bevacizumab and chemotherapy versus bevacizumab and chemotherapy…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating vaccine therapy using sargramostim (GM-CSF) in patients with HER2-positive stage III-IV breast cancer or o…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Diagnosing Ovarian Cysts - the DOC Study
Completed clinical trial from Rigshospitalet, Denmark, the DOC Study, evaluating diagnostic methods for ovarian cysts and their ability to d…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors [Phase 2]
A Phase 2 study of seribantumab in adults with NRG1 gene fusion-positive advanced solid tumors has been terminated, with results posted in A…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors
A completed clinical trial update examining metabolite levels in ovarian cancer patients receiving maintenance PARP inhibitors.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors [Phase 1, Phase 2]
Clinical trial update for TT-10 and TT-4 (Portage Biotech) exploring single-agent and combination therapy in advanced solid tumors, with rec…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation [Phase 2]
Phase 2 trial evaluating bevacizumab and/or niraparib in patients with recurrent endometrial and/or ovarian cancer harboring ARID1A mutation…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Implementing Enhanced Recovery After Surgery (ERAS) Pathways In Major Gynecologic Oncology Operations In Greece [NA]
A completed clinical trial conducted in Greece assessed the implementation of Enhanced Recovery After Surgery pathways in major gynecologic …
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial update of MOv19-BBz CAR T cells targeting aFR-expressing recurrent high-grade serous ovarian, fallopian tube, or primary perit…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer [Phase 4]
Phase 4 trial to evaluate the safety of Niraparib tablets in adult women with advanced or relapsed epithelial ovarian cancer; the study is n…